Compare AVDL & SONO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVDL | SONO |
|---|---|---|
| Founded | 2015 | 2002 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Consumer Electronics/Video Chains |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.2B |
| IPO Year | 1996 | 2018 |
| Metric | AVDL | SONO |
|---|---|---|
| Price | $21.51 | $15.87 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 3 |
| Target Price | $18.38 | ★ $19.67 |
| AVG Volume (30 Days) | ★ 1.6M | 1.3M |
| Earning Date | 03-02-2026 | 02-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $248,517,000.00 | ★ $1,443,276,000.00 |
| Revenue This Year | $65.47 | $4.35 |
| Revenue Next Year | $30.88 | $7.90 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 79.88 | N/A |
| 52 Week Low | $6.38 | $7.63 |
| 52 Week High | $23.57 | $19.82 |
| Indicator | AVDL | SONO |
|---|---|---|
| Relative Strength Index (RSI) | 56.85 | 31.36 |
| Support Level | $21.45 | $16.49 |
| Resistance Level | $21.60 | $17.32 |
| Average True Range (ATR) | 0.08 | 0.64 |
| MACD | -0.05 | -0.18 |
| Stochastic Oscillator | 48.78 | 2.28 |
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.
Sonos Inc is an audio company dedicated to elevating life through sound, offering a connected platform that brings together music, movies, stories, and conversations. Its portfolio includes home theater speakers, components, plug-in and portable speakers and headphones, known for exceptional sound, thoughtful design, ease of use and seamless access to audio content. Its partner products and other revenue categories include accessories for home integration, such as custom-designed stands, mounts, and shelving units, along with partnerships for architectural speakers and automotive sound systems, as well as licensing, advertising revenue, and subscription-based services. The company operates in the United States and other countries, with the majority of revenue coming from the United States.